IRIS
RICCARDI, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.395
NA - Nord America 1.761
EU - Europa 1.742
SA - Sud America 334
AF - Africa 64
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.297
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.701
SG - Singapore 1.012
RU - Federazione Russa 735
IT - Italia 577
CN - Cina 501
VN - Vietnam 463
BR - Brasile 279
HK - Hong Kong 176
DE - Germania 101
FR - Francia 82
GB - Regno Unito 45
IN - India 43
NL - Olanda 41
JP - Giappone 38
KR - Corea 35
CA - Canada 34
FI - Finlandia 30
AR - Argentina 27
ES - Italia 25
BD - Bangladesh 24
CI - Costa d'Avorio 24
IE - Irlanda 18
SE - Svezia 16
BE - Belgio 15
MX - Messico 13
PH - Filippine 12
PL - Polonia 12
AT - Austria 11
ID - Indonesia 11
IQ - Iraq 11
MA - Marocco 11
TH - Thailandia 11
ZA - Sudafrica 11
CO - Colombia 8
EC - Ecuador 8
PK - Pakistan 6
UA - Ucraina 6
GR - Grecia 5
LT - Lituania 5
TR - Turchia 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
JO - Giordania 4
KE - Kenya 4
MY - Malesia 4
BH - Bahrain 3
EG - Egitto 3
HN - Honduras 3
JM - Giamaica 3
KG - Kirghizistan 3
LB - Libano 3
NP - Nepal 3
RO - Romania 3
SA - Arabia Saudita 3
UY - Uruguay 3
UZ - Uzbekistan 3
BO - Bolivia 2
CL - Cile 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EE - Estonia 2
IL - Israele 2
NI - Nicaragua 2
PT - Portogallo 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
TZ - Tanzania 2
AL - Albania 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MQ - Martinica 1
MT - Malta 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
QA - Qatar 1
RS - Serbia 1
RW - Ruanda 1
SI - Slovenia 1
SN - Senegal 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
ZM - Zambia 1
ZW - Zimbabwe 1
Totale 6.297
Salva come PNG Salva come JPEG
Città #
Singapore 493
San Jose 216
Moscow 196
Chandler 186
Ashburn 171
Hong Kong 168
Beijing 154
Naples 146
Hefei 134
Ho Chi Minh City 129
Hanoi 106
Santa Clara 97
Napoli 96
Lauterbourg 45
Los Angeles 41
Dong Ket 40
Millbury 36
The Dalles 34
Munich 29
New York 28
Rome 28
Tokyo 27
Seoul 26
Amsterdam 25
Council Bluffs 25
Lawrence 25
Milan 25
Nanjing 25
São Paulo 25
Des Moines 24
Boston 23
Buffalo 23
Redondo Beach 23
Da Nang 19
Dallas 17
Nuremberg 17
Madrid 15
Frankfurt am Main 12
Houston 12
Kochi 12
Princeton 12
Turku 11
Wilmington 11
Belo Horizonte 10
Düsseldorf 10
Rio de Janeiro 10
Warsaw 10
Brussels 9
Ottawa 9
Seattle 9
Stockholm 9
Atlanta 8
Casablanca 8
Catania 8
Haiphong 8
Hải Dương 8
Lappeenranta 8
London 8
Montreal 8
Orem 8
Redwood City 8
Vienna 8
Denver 7
Guangzhou 7
Manchester 7
Norwalk 7
Torre del Greco 7
Turin 7
Bangkok 6
Biên Hòa 6
Can Tho 6
Caserta 6
Chennai 6
Chicago 6
Salerno 6
Toronto 6
Boscoreale 5
Dhaka 5
Fairfield 5
Helsinki 5
Jiaxing 5
Johannesburg 5
Philadelphia 5
Thái Nguyên 5
Villafranca Tirrena 5
Woodbridge 5
Baghdad 4
Bexley 4
Brasília 4
Cinisello Balsamo 4
Curitiba 4
Fisciano 4
Forlì 4
Goiânia 4
Guarulhos 4
Guayaquil 4
Las Vegas 4
Mexico City 4
Nanchang 4
Newark 4
Totale 3.367
Salva come PNG Salva come JPEG
Nome #
BENZODIFURAN DERIVATIVES AS POTENTIAL ANTIPROLIFERATIVE AGENTS: POSSIBLE CORRELATION BETWEEN THE BIOACTIVITY AND THEIR AGGREGATION PROPERTIES 178
"dressing up" an Old Drug: An Aminoacyl Lipid for the Functionalization of Ru(III)-Based Anticancer Agents 169
Self-assembly of thyminyl l-tryptophanamide (TrpT) building blocks for the potential development of drug delivery nanosystems 167
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action. 165
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer 163
Stability is not everything the case of the cyclization of the thrombin binding aptamer 157
Ru(III) complexes for anticancer therapy: the importance of being nucleolipidic 147
Anticancer activity of a cationic Ru-based nanosystem in a human xenograft model of breast cancer 146
On the pH-Modulated Ru-Based Prodrug Activation Mechanism 145
Fighting the Huntington’s Disease with a G-Quadruplex-Forming Aptamer Specifically Binding to Mutant Huntingtin Protein: Biophysical Characterization, In Vitro and In Vivo Studies 141
Preclinical validation of an original Ru(III)-based nanosystem in human models of breast cancer 138
Nucleolipidic-based liposomes effectively deliver a Ru(III) complex across cell membranes to nuclei promoting in concert apoptosis and autophagy in human models of breast cancer 137
Fluorescence Sensing Using DNA Aptamers in Cancer Research and Clinical Diagnostics 137
Bioengineered lipophilic Ru(III) complexes as potential anticancer agents 136
Insights into the G-rich VEGF-binding aptamer V7t1: when two G-quadruplexes are better than one! 136
Exploring the conformational behaviour and aggregation properties of lipid-conjugated AS1411 aptamers 135
A first-in-class and a fished out anticancer platinum compound:: Cis -[PtCl2(NH3)2] and cis -[PtI2(NH3)2] compared for their reactivity towards DNA model systems 134
Truncated Analogues of a G-Quadruplex-Forming Aptamer Targeting Mutant Huntingtin: Shorter Is Better! 133
G-quadruplex-based aptamers against protein targets in therapy and diagnostics 130
A terminal functionalization strategy reveals unusual binding abilities of anti-thrombin anticoagulant aptamers 127
Directing in Vitro Selection towards G‐quadruplex‐forming Aptamers to Inhibit HMGB1 Pathological Activity 127
Tuning the polymorphism of the anti-VEGF G-rich V7t1 aptamer by covalent dimeric constructs 126
Benzodifurans for biomedical applications: BZ4, a selective anti-proliferative and anti-amyloid lead compound 124
G-Quadruplex Forming Oligonucleotides as Anti-HIV Agents 123
Synthesis, DNA binding studies, and antiproliferative activity of novel Pt(II)-complexes with an L-alanyl-based ligand 122
Fluorescent Thrombin Binding Aptamer-Tagged Nanoparticles for an Efficient and Reversible Control of Thrombin Activity 119
Insights into the Small Molecule Targeting of Biologically Relevant G-Quadruplexes: An Overview of NMR and Crystal Structures 118
Anti-VEGF DNA-based aptamers in cancer therapeutics and diagnostics 118
Disentangling the Structure-Activity Relationships of Naphthalene Diimides as Anticancer G-Quadruplex-Targeting Drugs 116
Safety and efficacy evaluation in vivo of a cationic nucleolipid nanosystem for the nanodelivery of a ruthenium(III) complex with superior anticancer bioactivity 115
Fine-tuning the properties of the thrombin binding aptamer through cyclization: Effect of the 5′-3′ connecting linker on the aptamer stability and anticoagulant activity 112
Affinity chromatography-based assays for the screening of potential ligands selective for G-quadruplex structures 112
Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity 111
Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem 111
Exploring the Binding of Natural Compounds to Cancer-Related G-Quadruplex Structures: From 9,10-Dihydrophenanthrenes to Their Dimeric and Glucoside Derivatives 109
AS1411-decorated niosomes as effective nanocarriers for Ru(III)-based drugs in anticancer strategies 108
G-quadruplex-based aptamers targeting human thrombin: Discovery, chemical modifications and antithrombotic effects 106
Dimeric and Multimeric DNA Aptamers for Highly Effective Protein Recognition 103
Selective light-up of dimeric G-quadruplex forming aptamers for efficient VEGF165 detection 102
Synthesis, antiproliferative activity, and DNA binding studies of nucleoamino acid-containing Pt(II) complexes 100
RuIII Complexes for Anticancer Therapy: The Importance of Being Nucleolipidic 99
Synthesis and characterization of multifunctional nanovesicles composed of POPC lipid molecules for nuclear imaging 93
Design, synthesis and characterization of cyclic nu172 analogues: A biophysical and biological insight 92
Charge-transfer interactions stabilize g-quadruplex-forming thrombin binding aptamers and can improve their anticoagulant activity 92
When annealing is detrimental: The case of HMGB1-targeting G-quadruplex aptamers 91
Modular symmetric ligands for selective recognition of cancer-relevant G-quadruplexes 85
Design, Synthesis, and Characterization of an Amphiphilic Lipoic Acid-Based Ru(III) Complex as a Versatile Tool for the Functionalization of Different Nanosystems 78
Ferroptosis Among the Antiproliferative Pathways Activated by a Lipophilic Ruthenium(III) Complex as a Candidate Drug for Triple-Negative Breast Cancer 75
Natural compounds from Juncus plants interacting with telomeric and oncogene G-quadruplex structures as potential anticancer agents 74
Investigating the Interaction of an Anticancer Nucleolipidic Ru(III) Complex with Human Serum Proteins: A Spectroscopic Study 73
Metal-Based Complexes in Cancer 68
Understanding the biological activities of vitamin d in type 1 neurofibromatosis: New insights into disease pathogenesis and therapeutic design 68
Probing naphthalene diimide and 3-hydroxypropylphosphate as end-conjugating moieties for improved thrombin binding aptamers: Structural and biological effects 62
Nanoparticle-guided brain drug delivery: Expanding the therapeutic approach to neurodegenerative diseases 60
Covalently linked dimers of a G-quadruplex-forming aptamer as HMGB1 inhibitors 47
Nucleic acid-based aptamers in therapeutics and diagnostics 44
G-Quadruplex-Forming Aptamers as Selective Inhibitors of HMGB1 Protein: a Journey from Design to Their Functional Validation 19
When the Position of Pendant Groups Makes the Difference in G-Quadruplex Behavior: The Case of Bis-Conjugated Thrombin-Binding Aptamers 10
Totale 6.433
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.540
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.540
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022234 0 0 1 7 5 7 7 10 37 10 66 84
2022/2023471 45 51 8 31 52 51 14 51 68 47 37 16
2023/2024334 11 68 43 27 17 26 24 34 4 0 45 35
2024/20251.657 75 98 14 33 28 105 150 109 83 174 623 165
2025/20263.167 328 346 420 278 557 99 270 182 366 201 57 63
2026/202730 30 0 0 0 0 0 0 0 0 0 0 0
Totale 6.433